Tilray Brands, Indivior, and Incannex Healthcare are the three Cannabis stocks to watch today, according to MarketBeat’s stock screener tool. Cannabis stocks are shares of publicly traded companies involved in the cultivation, processing or distribution of cannabis and related products. By buying these securities, investors gain exposure to both medicinal and recreational marijuana markets as well as ancillary services such as biotechnology research, packaging or retail operations. Because the legal and regulatory environment for cannabis is still evolving, these stocks often exhibit higher volatility and risk than those in more established industries. These companies had the highest dollar trading volume of any Cannabis stocks within the last several days.
Tilray Brands (TLRY)
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.
Indivior (INDV)
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Read Our Latest Research Report on INDV
Incannex Healthcare (IXHL)
Incannex Healthcare Inc., a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It develops products for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, pain, and other indications.
Read Our Latest Research Report on IXHL
Featured Articles
- MarketBeat’s Top Five Stocks to Own in September 2025
- Bloom Energy Booms on AI Power Demand and Analyst Upgrades
- New Catalysts Build Positive Pressure on Intel Stock
- Can Apple’s iPhone 17 and AI Push Its Stock to New Highs?
- Oracle to Hit $1 Trillion Valuation in 2025: Here’s Why
- General Mills Is a Generational Opportunity for Income Investors